SKN | Amaero Raises $20 Million in Downsized Nasdaq IPO at $4.25 per Share
Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, raised $20 million in its Nasdaq cross-listing by offering...
SKN | American Century ETF Trust Expands Its Investment Reach as Active ETFs Gain Ground
American Century ETF Trust is part of a growing exchange-traded fund business offering investors access to actively managed equity, fixed-income and international strategies. Rather...
SKN | Amaero Stock Draws Investor Attention as Advanced Manufacturing and Defense Demand Drive Expansion
Amaero Inc. is attracting attention in the U.S. stock market as demand for advanced metal powders and specialized manufacturing technologies creates opportunities across aerospace,...
SKN | Iambic Therapeutics Raises $150 Million in AI-Driven Biotech IPO
Iambic Therapeutics, a clinical-stage biotechnology company using artificial intelligence to develop small-molecule cancer treatments, raised $150 million in its initial public offering. The company...
SKN | BioVentrix Withdraws Planned $17 Million IPO for Minimally Invasive Heart Failure Treatments
BioVentrix, a medical device company developing minimally invasive treatments for heart failure, has withdrawn its plans for an initial public offering. The Mansfield, Massachusetts-based...